ID 139 - Witamina C

PL: Witamina C
EN: Vitamin C
Pdf: vitamin C

Oświadczenie (4)

Oświadczenie (2)

1. Charakterystyka żywności / składnika

The food constituent that is the subject of the health claims is vitamin C (L-ascorbic acid, ascorbate), which is a well recognised nutrient and is measurable in foods by established methods.
Vitamin C occurs naturally in foods and is authorised for addition to foods (Annex I of the Regulation (EC) No 1925/20066 and Annex I of Directive 2002/46/EC7). This evaluation applies to vitamin C naturally present in foods and those forms authorised for addition to foods (Annex II of the Regulation (EC) No 1925/2006 and Annex II of Directive 2002/46/EC).
The Panel considers that the food constituent, vitamin C, which is the subject of the health claims, is sufficiently characterised.

2.1. Zmniejszenie zmęczenia (ID 139, 2622)

The claimed effect is “vitamin/mineral supplementation to reduce fatigue and tiredness in situations of inadequate micronutrient status”. The Panel assumes that the target population is the general population.
In the context of the proposed wording and clarifications provided by Member States, the Panel assumes that the claimed effect refers to the reduction of tiredness and fatigue.
The Panel considers that reduction of tiredness and fatigue is a beneficial physiological effect.

3. Naukowe uzasadnienia wpływu na zdrowie człowieka - 

The evidence provided by consensus opinions/reports from authoritative bodies and reviews shows that there is consensus on the role of vitamin C in the body (Bender, 2003; Garrow et al., 2000; IoM, 2000; NNR, 2004; Sadler et al., 1999; Levine et al., 2006; EVM, 2002). Vitamin C is an electron donor, or reducing agent, and its functions are attributable to this action (Levine et al., 2006). Vitamin C acts as a free radical scavenger in the body and as electron donor (and cofactor) for eight human enzymes, three of which participate in the biosynthesis (and cross-linking) of collagen and other components of the connective tissue, two of which are required in the biosynthesis of carnitine, one of which is required in tyrosine metabolism and two of which are required in the biosynthesis of the catecholamines adrenaline and noradrenaline (which act as neurotransmitters) and in the amidation of peptide hormones.

3.1. Zmniejszenie zmęczenia (ID 139, 2622)

The evidence provided by consensus opinions/reports from authoritative bodies and reviews shows that weakness and fatigue are among the symptoms of vitamin C deficiency (IoM, 2000; Lukaski, 2004). These symptoms respond to vitamin C supplementation (Levine et al., 1996).
The Panel concludes that a cause and effect relationship has been established between the dietary intake of vitamin C and reduction of tiredness and fatigue.

4.1. Zmniejszenie zmęczenia (ID 139, 2622)

The Panel considers that the following wording reflects the scientific evidence: “Vitamin C can contribute to the reduction of tiredness and fatigue”.

5. Warunki i możliwe ograniczenia stosowania oświadczenia

The Panel considers that in order to bear the claims a food should be at least a source of vitamin C as per Annex to Regulation (EC) No 1924/2006. Such amounts can be easily consumed as part of a balanced diet. The target population is the general population.

Warunki i możliwe ograniczenia stosowania oświadczenia

Must meet minimum requirements for use of the claim "source of [name of vitamin/s] and/or [name of mineral/s]," as per Annex to Regulation 1924/2006. Agency guidance for supplements is that products containing >1000 mg of Vitamin C should carry the label